Sik Alsaima em wanpela sik bilong kru i save go bikpela na i save painim ol lapun.
Sik Alsaima i save kamap taim man i go lapun, na planti man i winim 65 krismas ol i kisim dispela sik.
Tasol sik Alsaima inap kamap long ol man i gat 30, 40, na 50 krismas samting, tasol dispela sik i no save kamap planti taim.
Ol samting bilong skin i save mekim sampela samting long sik Alsaima.
Ol man i gat dispela sik long famili bilong ol, ol inap kisim dispela sik.
Na tu, sampela senis i kamap long jin bilong man, olsem jin APOE-e4, dispela inap mekim na man i kisim sik Alsaima.
Sampela samting moa inap mekim na man i kisim sik Alsaima, em sapos em i bin kisim bagarap long het, sik bilong klok, na ol samting em i save mekim long olgeta de olsem smok, patpela skin, na i no eksasais.
Em i bikpela samting long save olsem sampela samting inap mekim na man i kisim sik Alsaima, tasol dispela i no wanpela pasin bilong ol lapun, na i no olgeta man i go lapun bai kisim dispela sik.
Kovacs GG: Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? Prion. 2016, 10 (5): 369-376.
Cankurtaran M, Yavuz BB, Cankurtaran ES, Halil M, Ulger Z, Ariogul S: Risk factors and type of dementia: vascular or Alzheimer? Arch Gerontol Geriatr. , 47 (1): 25-34.
Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E: Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res. 2016, 115 (8): 3169-74.
Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S: Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Aging. , 11 (4): 338-41.
Bakhtiari S, Moghadam NB, Ehsani M, Mortazavi H, Sabour S, Bakhshi M: Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer? J Clin Diagn Res. 2017, 11 (1): ZC58-ZC60.
['Toksave: sik']
['Dispela Web-sait i bilong skulim na givim save tasol long ol man, na i no bilong givim tok bilong helpim ol sikman o helpim ol narapela long sait bilong helt.']
['Ol i no ken yusim ol dispela tok bilong helpim ol long save long sik bilong ol, na ol man i laik kisim helpim long ol samting bilong helt, ol i mas toktok wantaim wanpela dokta.']
['Tingim, ol kompiuta i save yusim ol kompiuta long kamapim ol bekim bilong ol askim, tasol ol i no save kolim stret ol namba, olsem namba bilong ol man i gat wanpela sik.']
['Oltaim yu mas kisim tingting bilong dokta o narapela lain i gat save long helpim yu long sait bilong helt sapos yu gat sik. No ken sakim tok bilong dokta o wet long kisim tingting bilong dokta, long wanem, yu ritim sampela tok long dispela Web-sait. Sapos yu ting yu gat sik, ringim 911 o go long haus sik i stap klostu.']
['Toksave: raits bilong man i bosim']
['Digital Millennium Copyright Act bilong 1998, 17 U.S.C. § 512 (the DMCA) i tok ol papa bilong ol samting i gat rait long wokim ol samting, sapos ol i ting ol samting i stap long Intenet i brukim ol lo bilong ol long Amerika.']
['Sapos yu bilip olsem sampela samting i stap long dispela Web-sait o ol sevis bilong mipela i brukim lo bilong kopirait bilong yu, yu (o agent bilong yu) inap salim toksave long mipela na askim mipela long rausim o pasim rot bilong yu long kisim dispela samting.']
['Ol i mas salim ol toksave long rot bilong e-mail (lukim hap "Kontek" bilong lukim e-mail atres). ']
['Lo bilong DMCA i tok olsem toksave bilong yu long ol man i bin brukim lo bilong kopirait i mas i gat ol dispela tok: (1) stori long ol samting i gat kopirait long en, em ol man i tok ol i bin brukim; (2) stori long ol samting i gat kopirait na ol tok bilong helpim mipela long painim ol dispela samting; (3) ol tok bilong yu bilong salim pas long mipela, olsem atres, telefon namba, na e-meil atres; (4) tok yu bin mekim olsem yu bilip tru olsem man i gat kopirait o agent bilong em i no orait long ol samting i stap long dispela websait.']
['(5) Yu mas raitim wanpela pepa na putim han bilong yu bilong tokaut olsem ol tok bilong dispela pepa i stret na yu gat namba long mekim ol samting bilong lukautim ol rait bilong man i bin wokim ol samting.']
['Na (6) wanpela sain o sain bilong man i gat rait long wokim dispela samting o bilong wanpela man i gat namba long mekim wok bilong dispela man.']
['Sapos yu no raitim olgeta dispela tok, dispela inap mekim na ol i no stretim kwik komplen bilong yu.']
['Kontektim']
['Plis salim e-mail long mipela sapos yu gat sampela askim o tingting.']
Who gets alzheimer?
Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects older adults.
The risk of developing Alzheimer's disease increases with age, and it is most common in people over the age of 65.
However, early-onset Alzheimer's can occur in people in their 30s, 40s, and 50s, although this is less common.
Genetics also play a role in the development of Alzheimer's disease.
People with a family history of the disease are at a higher risk of developing it themselves.
Additionally, certain genetic mutations, such as the APOE-e4 gene, can increase the likelihood of developing Alzheimer's.
Other risk factors for Alzheimer's disease include a history of head injuries, cardiovascular disease, and lifestyle factors such as smoking, obesity, and lack of exercise.
It is important to note that while certain factors can increase the risk of developing Alzheimer's disease, it is not a normal part of aging, and not everyone who ages will develop the disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Klostu']
['BioMedLib i yusim ol kompiuta (machine-learning algorithms) long kamapim ol askim na bekim.']
['Pastaim mipela i skelim 35 milion buk bilong ol saientis long ol buk na nius bilong ol dokta na saientis long ol marasin bilong ol man.']
